|
|
| | 3H-Pyrrolo[3,4-c]pyridin-3-one, 7-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-1,2-dihydro-4-[[4-[(3S)-3-(1-hydroxy-1-methylethyl)-1-piperidinyl]phenyl]amino]- Basic information |
| | 3H-Pyrrolo[3,4-c]pyridin-3-one, 7-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-1,2-dihydro-4-[[4-[(3S)-3-(1-hydroxy-1-methylethyl)-1-piperidinyl]phenyl]amino]- Chemical Properties |
| density | 1.41±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.08±0.20(predicted) |
| | 3H-Pyrrolo[3,4-c]pyridin-3-one, 7-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-1,2-dihydro-4-[[4-[(3S)-3-(1-hydroxy-1-methylethyl)-1-piperidinyl]phenyl]amino]- Usage And Synthesis |
| Uses | HPK1-IN-49 (Compound I-4) is an inhibitor for hematopoietic progenitor kinase 1 (HPK1) with an IC50 >100 nM[1]. | | IC 50 | HPK1 | | References | [1] Kaila N, et al., SUBSTITUTED PYRROLO[3,4-c]PYRIDINES AS HPK1 ANTAGONISTS. US20240190895. |
| | 3H-Pyrrolo[3,4-c]pyridin-3-one, 7-(7-fluoroimidazo[1,2-a]pyridin-3-yl)-1,2-dihydro-4-[[4-[(3S)-3-(1-hydroxy-1-methylethyl)-1-piperidinyl]phenyl]amino]- Preparation Products And Raw materials |
|